The S&P 500 has risen about 16% this year and is hovering near its all-time high. It looks historically expensive at 31 times ...
An expanded partnership deal and a $2 billion investment raised confidence in this company's long-term growth prospects.
The innovative fuel cell provider is tied at the hip to the artificial intelligence (AI) build out.
Investing in Halozyme Therapeutics is a compelling way to gain exposure to the broader healthcare and biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback